Pediatric Hematopoietic Stem Cell Transplant in the COVID-19 Pandemic: The Problems We Faced and The Strategies We Adopted

AuthorTahereh Rostamien
AuthorSeied Asadollah Mousavien
AuthorSoroush Raden
AuthorAzadeh Kiumarsien
AuthorAmir Hesabien
AuthorMohammadreza Rostamien
AuthorSeied Amirhosein Mirhoseinien
AuthorAmirabbas Hedayatiaslen
OrcidSeied Asadollah Mousavi [0000-0001-7360-0064]en
Issued Date2020-09-01en
AbstractIntroduction: The COVID-19 pandemic has challenged hematopoietic stem cell transplant (HSCT) clinicians to profoundly re-organize their medical care to reduce complications without compromising patients’ inquiries. Since this pandemic is a foggy novel disease, scientific approved data are not available, and so decisions should be made based on expert opinions. Methods: This is a pediatric HSCT center experience, including preventive and solving strategies specifically undertaken to address problems caused by the COVID-19 outbreak. Results: In this report, we have shared our experience to alert healthcare professionals worldwide to get prepared accordingly. Conclusion: We are not aware of the duration or outcome of the pandemic, but we are intended to learn from our experiences and figure out the best strategies to minimize the possible harms.en
DOIhttps://doi.org/10.5812/pedinfect.104228en
KeywordSARS-Cov-2en
KeywordCOVID-19en
KeywordPediatricen
KeywordHematopoietic Stem Cell Transplanten
KeywordHSCTen
PublisherBrieflandsen
TitlePediatric Hematopoietic Stem Cell Transplant in the COVID-19 Pandemic: The Problems We Faced and The Strategies We Adopteden
TypeDiscussionen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
apid-8-4-104228.pdf
Size:
151.48 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF